RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Peng Ma to Microsomes, Liver

This is a "connection" page, showing publications Peng Ma has written about Microsomes, Liver.
Connection Strength

0.224
  1. Zhang Q, Ma P, Cole RB, Wang G. In vitro metabolism of indomethacin morpholinylamide (BML-190), an inverse agonist for the peripheral cannabinoid receptor (CB(2)) in rat liver microsomes. Eur J Pharm Sci. 2010 Sep 11; 41(1):163-72.
    View in: PubMed
    Score: 0.093
  2. Zhang Q, Ma P, Wang W, Cole RB, Wang G. Characterization of rat liver microsomal metabolites of AM-630, a potent cannabinoid receptor antagonist, by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. J Mass Spectrom. 2004 Jun; 39(6):672-81.
    View in: PubMed
    Score: 0.061
  3. Zhang Q, Ma P, Iszard M, Cole RB, Wang W, Wang G. In vitro metabolism of R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo [1,2,3-de]1,4-benzoxazinyl]-(1-naphthalenyl) methanone mesylate, a cannabinoid receptor agonist. Drug Metab Dispos. 2002 Oct; 30(10):1077-86.
    View in: PubMed
    Score: 0.054
  4. Zhang Q, Ma P, Wang W, Cole RB, Wang G. In vitro metabolism of diarylpyrazoles, a novel group of cannabinoid receptor ligands. Drug Metab Dispos. 2005 Apr; 33(4):508-17.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support